• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    Sorrento Therapeutics, Inc. (SRNE)

    -NasdaqCM
    12.68 Down 0.97(7.11%) 4:00PM EDT
    |After Hours : 12.70 Up 0.02 (0.16%) 4:30PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:13.65
    Open:13.67
    Bid:12.41 x 300
    Ask:13.18 x 7800
    1y Target Est:27.50
    Beta:0.523193
    Next Earnings Date:N/A
    Day's Range:12.61 - 13.71
    52wk Range:3.10 - 26.80
    Volume:356,888
    Avg Vol (3m):821,894
    Market Cap:478.82M
    P/E (ttm):N/A
    EPS (ttm):-1.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRNE

    Key Statistics

    Forward P/E (1 yr):3.84
    P/S (ttm):122.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.01
    Quarterly EPS Est (Sep-15) :0.80
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sorrento Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback